Expertise
Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.
The PCCTC was formed to address critically unmet needs in prostate cancer. Our mission is to design, implement, and complete early-phase process driven clinical trials, translating scientific discoveries to improved standards of care.
The PCCTC is changing how prostate cancer drugs are developed. Our unique infrastructure facilitates project co-development between investigators, clinical research sites and industry partners.
Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.
Practical considerations and challenges for germline genetic testing in patients with pros...
Learn More“Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Futu...
Learn MoreDr. Charles Ryan (University of Minnesota) is joined by the PCCTC’s CEO, Jake Vinson...
Learn MoreA commitment to addressing prostate cancer health disparities.
Learn MoreDr. Alicia Morgans (Northwestern University Feinberg School of Medicine) welcomes PCCTC Me...
Learn MoreJoin our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.